Bone morphogenetic proteins: A powerful osteoinductive compound with non-negligible side effects and limitations

BioFactors

Volumn 40, Issue 5, 2014, Pages 459-481

  Oryan, Ahmad ^a   Alidadi, Soodeh ^a   Moshiri, Ali ^a   Bigham Sadegh, Amin ^b  

^a SHIRAZ UNIVERSITY   (Iran)

^b SHAHREKORD UNIVERSITY   (Iran)

Author keywords

BMPs substitutes; Bone healing; Bone morphogenetic protein; Bone tissue engineering and regenerative medicine; Delivery system

Indexed keywords

BONE DENSITY CONSERVATION AGENT; BONE MORPHOGENETIC PROTEIN;

ANIMAL; BONE DISEASES; BONE REGENERATION; DRUG EFFECTS; FRACTURES, BONE; HUMAN; SIGNAL TRANSDUCTION;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; FRACTURES, BONE; HUMANS; SIGNAL TRANSDUCTION;

EID: 84921325005     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1177     Document Type: Review

References (165)

1. Lee, S. S., Huang, B. J., Kaltz, S. R., Sur, S., Newcomb, C. J., et al. (2013) Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds. Biomaterials 34, 452-459.
2. Oryan, A., Alidadi, S., and Moshiri, A. (2013) Current concerns regarding healing of bone defects. Hard Tissue 2, 13.
3. Sterling, J. A. and Guelcher, S. A. (2014) Biomaterial scaffolds for treating osteoporotic bone. Curr. Osteoporos. Rep. 12, 48-54.
4. Blokhuis, T. J., Calori, G. M., and Schmidmaier, G. (2013) Autograft versus BMPs for the treatment of non-unions: what is the evidence? Injury 44, S40-S42.
5. Bigham-Sadegh, A., Oryan, A., Mirshokraei, P., Shadkhast, M., and Basiri, E. (2013) Bone tissue engineering with periosteal-free graft and pedicle omentum. ANZ J. Surg. 83, 255-261.
6. Meimandi-Parizi, A., Oryan, A., and Moshiri A. (2013) Tendon tissue engineering and its role on healing of the experimentally induced large tendon defect model in rabbits: a comprehensive in vivo study. PLoS One 8, e73016.
7. Moshiri, A. and Oryan, A. (2012) Role of tissue engineering in tendon reconstructive surgery and regenerative medicine: current concepts, approaches and concerns. Hard Tissue 1, 11.
8. Oryan, A., Moshiri, A., and Meimandi-Parizi, A. (2014) In vitro characterization of a novel tissue engineered based hybridized nano and micro structured collagen implant and its in vivo role on tenoinduction, tenoconduction, tenogenesis and tenointegration. J. Mater. Sci. Mater. Med. 25, 873-897.
9. Moshiri, A. and Oryan, A. (2013) Tendon and ligament tissue engineering, healing and regenerative medicine. J. Sports Med. Doping Stud. 3, 126.
10. Moshiri, A., Oryan, A., and Meimandi-Parizi, A. (2013) Role of tissue-engineered artificial tendon in healing of a large Achilles tendon defect model in rabbits. J. Am. Coll. Surg. 217, 421-441.
11. Bigham-Sadegh, A., Mirshokraei, P., Karimi, I., Oryan, A., Aparviz, A., et al. (2012) Shafiei-Sarvestani Z. Effects of adipose tissue stem cell concurrent with greater omentum on experimental long-bone healing in dog. Connect. Tissue Res. 53, 334-342.
12. Oryan, A., Bigham-Sadegh, A., and Abbasi-Teshnizi, F. (2014) Effects of osteogenic medium on healing of the experimental critical bone defect in a rabbit model. Bone 63, 53-60.
13. Zhao, Y. P., Tian, Q. Y., Frenkel, S., and Liu, C. J. (2013) The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF/TNFR signaling. Biomaterials 34, 6412-6421.
14. Oryan, A., Alidadi, S., Moshiri, A., and Maffulli, N. (2014) Bone regenerative medicine: classic options, novel strategies, and future directions. J. Orthop. Surg. Res. 9, 18.
15. Babu, B. V., Sjekar, S., Bulchandani, D., Goyal, M., and Soni, N. (2013) Bone morphogenetic proteins: a review. J. Res. Adv. Dent. 2, 91-98.
16. Moshiri, A. and Oryan, A. (2011) Structural and functional modulation of early healing of full-thickness superficial digital flexor tendon rupture in rabbits by repeated subcutaneous administration of exogenous human recombinant basic fibroblast growth factor. J. Foot Ankle Surg. 50, 654-662.
17. Oryan, A. and Moshiri, A. (2014) Recombinant fibroblast growth protein enhances healing ability of experimentally induced tendon injury in vivo. J. Tissue Eng. Regen. Med. 8, 421-431.
18. Oryan, A. and Moshiri, A. (2013) Tissue engineering: alternative option in managing large and massive tissue deficits. Trop. Med. Surg. 1, e101.
19. Lissenberg-Thunnissen, S. N., de Gorter, D. J., Sier, C. F., and Schipper, I. B. (2011) Use and efficacy of bone morphogenetic proteins in fracture healing. Int. Orthop. 35, 1271-1280.
20. Carreira, A. C., Lojudice, F. H., Halcsik, E., Navarro, R. D., Sogayar, M. C., et al. (2014) Bone morphogenetic proteins: facts, challenges, and future perspectives. J. Dent. Res., ;93, 335-345.
21. Garimella, R., Tague, S. E., Zhang, J., Belibi, F., Nahar, N., et al. (2008) Expression and synthesis of bone morphogenetic proteins by osteoclasts: a possible path to anabolic bone remodeling. J. Histochem. Cytochem. 56, 569-577.
22. Cottrell, J. A., Keane, O., Lin, S. S., and O'Connor, J. P. (2014) BMP-2 modulates expression of other growth factors in a rat fracture healing model. J. Appl. Biomed. 12, 127-135.
23. Ehnert, S., Zhao, J., Pscherer, S., Freude, T., Dooley, S., et al. (2012) Transforming growth factor β1 inhibits bone morphogenetic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy? BMC Med. 10, 101.
24. Arrabal, P. M., Visser, R., Santos-Ruiz, L., Becerra, J., and Cifuentes, M. (2013) Osteogenic molecules for clinical applications: improving the BMP-collagen system. Biol. Res. 46, 421-429.
25. Lungu, A., Titorencu, I., Albu, M. G., Florea, N. M., Vasile, E., et al. (2011) The effect of BMP-4 loaded in 3D collagen-hyaluronic acid scaffolds on biocompatibility assessed with MG 63 osteoblast-like cells. Digest. J. Nanomater. Biostruct. 6, 1897-1908.
26. Moshiri, A., Oryan, A., Meimandi-Parizi, A., Silver, I. A., Tanideh, N., et al. (2013) Effectiveness of hybridized nano- and microstructure biodegradable, biocompatible, collagen-based, three-dimensional bioimplants in repair of a large tendon-defect model in rabbits.
27. Doty, H. A., Leedy, M. R., Courtney, H. S., Haggard, W. O., and Bumgardner, J. D. (2014) Composite chitosan and calcium sulfate scaffold for dual delivery of vancomycin and recombinant human bone morphogenetic protein-2. J. Mater. Sci. Mater. Med. 25, 1449-1459.
28. Kim, S., Kang, Y., Krueger, C. A., Sen, M., Holcomb, J. B., et al. (2012) Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation. Acta Biomater. 8, 1768-1777.
29. Buranawat, B., Di Silvio, L., Deb, S., Nannmark, U., Sennerby, L., et al. (2014) Evaluation of a β-calcium metaphosphate bone graft containing bone morphogenetic protein-7 in rabbit maxillary defects. J. Periodontol. 85, 298-307.
30. Seo, J. P., Tsuzuki, N., Haneda, K., Furuoka, H., Tabata, Y., et al. (2014) Osteoinductivity of gelatin/β-tricalcium phosphate sponges loaded with different concentrations of mesenchymal stem cells and bone morphogenetic protein-2 in an equine bone defect model. Vet. Res. Commun. 3, 73-80.
31. Lee, D. W., Yun, Y. P., Park, K., and Kim, S. E. (2012) Gentamicin and bone morphogenic protein-2 (BMP-2)-delivering heparinized-titanium implant with enhanced antibacterial activity and osteointegration. Bone 50, 974-982.
32. Hannink, G., Geutjes, P. J., Daamen, W. F., and Buma, P. (2013) Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2. J. Mater. Sci. Mater. Med. 24, 325-332.
33. Assaf, K., Duek, E. A. R., and Oliveira, N. M. (2013) Efficacy of a combination of simvastatin and poly(DL-lactic-co-glycolic acid) in stimulating the regeneration of bone defects. Mater. Res. 16, 215-220.
34. Hu, J., Zhou, Y., Huang, L., Liu, J., and Lu, H. (2014) Effect of nano-hydroxyapatite coating on the osteoinductivity of porous biphasic calcium phosphate ceramics. BMC Musculoskelet. Disord. 15, 114.
35. Masala, S., Taglieri, A., Chiaravalloti, A., Calabria, E., Morini, M., et al. (2014) Thoraco-lumbar traumatic vertebral fractures augmentation by osteo-conductive and osteo-inductive bone substitute containing strontium-hydroxyapatite: our experience. Neuroradiology 56, 459-466.
36. Schneider, H., Sedaghati, B., Naumann, A., Hacker, M. C., and Schulz-Siegmund, M. (2014) Gene silencing of chordin improves BMP-2 effects on osteogenic differentiation of human adipose tissue-derived stromal cells. Tissue Eng. Part A 20, 335-345.
37. Urist, M. R. (1965) Bone: formation by autoinduction. Science 150, 893-899.
38. Urist, M. R. and Strates, B. S. (1971) Bone morphogenetic protein, J. Dent. Res. 50, 1392-1406.
39. Jain, A. P., Pundir, S., and Sharma, A. (2013) Bone morphogenetic proteins: the anomalous molecules. J. Indian Soc. Periodontol. 17, 583-586.
40. Davidson, A. J., Postlethwait, J. H., Yan, Y. L., Beier, D. R., van Doren, C., et al. (1999) Isolation of zebrafish gdf7 and comparative genetic mapping of genes belonging to the growth/differentiation factor 5, 6, 7 subgroup of the TGF-beta superfamily. Genome Res. 9, 121-129.
41. Saito, S., Yano, K., Sharma, S., McMahon, H. E., and Shimasaki, S. (2008) Characterization of the post-translational modification of recombinant human BMP-15 mature protein. Protein Sci. 17, 362-370.
42. Takami, A., Kato, H., Takagi, R., and Miyashita, T. (2013) Studies on the Pinctada fucata BMP-2 gene: structural similarity and functional conservation of its osteogenic potential within the animal kingdom. Int. J. Zool. 2013, 9.
43. Ozkaynak, E., Schnegelsberg, P. N., Jin, D. F., Clifford, G. M., Warren, F. D., et al. (1992) Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. J. Biol. Chem. 267, 25220-25227.
44. Hotten, G., Neidhardt, H., Jacobowsky, B., and Pohl, J. (1994) Cloning and expression of recombinant human growth/differentiation factor 5. Biochem. Biophys. Res. Commun. 204, 646-452.
45. Allendorph, G. P., Isaacs, M. J., Kawakami, Y., Izpisua Belmonte, J. C., and Choe, S. (2007) BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors. Biochemistry 46, 12238-12247.
46. Poli, M., Girelli, D., Campostrini, N., Maccarinelli, F., Finazzi, D., et al. (2011) Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo. Blood 117, 997-1004.
47. Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., et al. (1988) Novel regulators of bone formation: molecular clones and activities. Science 242, 1528-1534.
48. Huh, J. B., Lee, H. J., Jang, J. W., Kim, M. J., Yun, P. Y., et al. (2011) Randomized clinical trial on the efficacy of Escherichia coli-derived rhBMP-2 with β-TCP/HA in extraction socket. J. Adv. Prosthodont. 3, 161-165.
49. Menendez, M. I., Clark, D. J., Carlton, M., Flanigan, D. C., Jia, G., et al. (2011) Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model. Osteoarthritis Cartilage 19, 1066-1075.
50. Tsiridis, E., Upadhyay, N., and Giannoudis, P. (2007) Molecular aspects of fracture healing: which are the important molecules? Injury 38, S11-S25.
51. Wulsten, D., Glatt, V., Ellinghaus, A., Schmidt-Bleek, K., Petersen, A., et al. (2011) Time kinetics of bone defect healing in response to BMP-2 and GDF-5 characterised by in vivo biomechanics. Eur. Cell Mater. 21, 177-192.
52. Chang, X., Lu, Y., Shibata, Y., Tsukazaki, T., and Yamaguchi, A. (2012) Role of bone morphogenetic proteins and their antagonists during fracture healing. J. Hard Tissue Biol. 21, 203-212.
53. McMahon, M. S. (2012) Bone morphogenic protein 3 signaling in the regulation of osteogenesis. Orthopedics 35, 920.
54. Berasi, S. P., Varadarajan, U., Archambault, J., Cain, M., Souza, T. A., et al. (2011) Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities. Growth Factors 29, 128-139.
55. Stewart, S., Gomez, A. W., Armstrong, B. E., Henner, A., and Stankunas, K. (2014) Sequential and opposing activities of Wnt and BMP coordinate zebrafish bone regeneration. Cell Rep. PII, S2211-1247(14)00011-4.
56. Zhang, W., Zhu, C., Wu, Y., Ye, D., Wang, S., et al. (2014) VEGF and BMP-2 promote bone regeneration by facilitating bone marrow stem cell homing and differentiation. Eur. Cell. Mater. 27, 1-12.
57. Ishida, K. and Haudenschild, D. R. (2013) Interactions between FGF21 and BMP-2 in osteogenesis. Biochem. Biophys. Res. Commun. 432, 677-682.
58. Su, J., Xu, H., Sun, J., Gong, X., and Zhao, H. (2013) Dual delivery of BMP-2 and bFGF from a new nano-composite scaffold, loaded with vascular stents for large-size mandibular defect regeneration. Int. J. Mol. Sci. 14, 12714-12728.
59. Papanna, M. C., Al-Hadithy, N., Somanchi, B. V., Sewell, M. D., Robinson, P. M., et al. (2012) The use of bone morphogenic protein-7 (OP-1) in the management of resistant non-unions in the upper and lower limb. Injury 43, 1135-1140.
60. Liu, Y., Liu, Y., Zhang, R., Huang, F., Yan, Z., et al. (2014) All-trans retinoic acid modulates bone morphogenic protein 9-induced osteogenesis and adipogenesis of preadipocytes through BMP/Smad and Wnt/β-catenin signaling pathways. Int. J. Biochem. Cell Biol. 47, 47-56.
61. Cho, T. J., Gerstenfeld, L. C., and Einhorn, T. A. (2002) Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J. Bone Miner. Res. 17, 513-520.
62. Rodgers, M. A., Brown, J. V., Heirs, M. K., Higgins, J. P., Mannion, R. J., et al. (2013) Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion. BMJ 346, f3981.
63. Rodgers, S. D., Marascalchi, B. J., Grobelny, B. T., Smith, M. L., and Samadani, U. (2013) Revision surgery after interbody fusion with rhBMP-2: a cautionary tale for spine surgeons. J. Neurosurg. Spine 18, 582-587.
64. Simmonds, M. C., Brown, J. V., Heirs, M. K., Higgins, J. P., Mannion, R. J., et al. (2013) Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data. Ann. Intern. Med. 158, 877-889.
65. Kodera, R., Miyazaki, M., Yoshiiwa, T., Kawano, M., Kaku, N., et al. (2014) Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model. Bone 58, 26-32.
66. de Freitas, R. M., Susin, C., Spin-Neto, R., Marcantonio, C., Wikesjo, U. M., et al. (2013) Horizontal ridge augmentation of the atrophic anterior maxilla using rhBMP-2/ACS or autogenous bone grafts: a proof-of-concept randomized clinical trial. J. Clin. Periodontol. 40, 968-975.
67. Wei, S., Cai, X., Huang, J., Xu, F., Liu, X., et al. (2012) Recombinant human BMP-2 for the treatment of open tibial fractures. Orthopedics 35, e847-e854.
68. Bae, I. H., Jeong, B. C., Kook, M. S., Kim, S. H., and Koh, J. T. (2013) B Evaluation of a thiolated chitosan scaffold for local delivery of BMP-2 for osteogenic differentiation and ectopic bone formation. Biomed. Res. Int. 2013, 878930.
69. Aro, H. T., Govender, S., Patel, A. D., Hernigou, P., Perera de Gregorio, A., et al. (2011) Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation. J. Bone Joint Surg. Am. 93, 801-808.
70. Vrijens, K., Lin, W., Cui, J., Farmer, D., Low, J., et al. (2013) Identification of small molecule activators of BMP signaling. PLoS One 8, e59045.
71. Yu, Y. Y., Lieu, S., Lu, C., Miclau, T., Marcucio, R. S., et al. (2010) Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair. Bone 46, 841-851.
72. Oryan, A., Moshiri, A., and Meimandi-Parizi, A. (2014) Implantation of a novel tissue-engineered graft in a large tendon defect initiated inflammation, accelerated fibroplasia and improved remodeling of the new Achilles tendon: a comprehensive detailed study with new insights. Cell Tissue Res. 355, 59-80.
73. Bigham-Sadegh, A. and Oryan, A. (2014) Basic concepts regarding fracture healing and the current options and future directions in managing bone fractures. Int. Wound J., in press.
74. Marsell, R. and Einhorn, T. A. (2009) The role of endogenous bone morphogenetic proteins in normal skeletal repair. Injury 40, S4-S7.
75. Chen, G., Deng, C., and Li, Y. P. (2012) TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int. J. Biol. Sci. 8, 272-288.
76. Peterson, R. S., Andhare, R. A., Rousche, K. T., Knudson, W., Wang, W., et al. (2004) CD44 modulates Smad1 activation in the BMP-7 signaling pathway. J. Cell Biol. 166, 1081-1091.
77. Kopf, J., Paarmann, P., Hiepen, C., Horbelt, D., and Knaus, P. (2014) BMP growth factor signaling in a biomechanical context. Biofactors 40, 171-187.
78. Kloen, P., Lauzier, D., and Hamdy, R. C. (2012) Co-expression of BMPs and BMP-inhibitors in human fractures and non-unions. Bone 51, 59-68.
79. Garulli, C., Kalogris, C., Pietrella, L., Bartolacci, C., Andreani, C., et al. (2014) Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling. Cell Signal 26, 352-362.
80. Beederman, M., Lamplot, J., Nan, G., Wang, J., Liu, X., et al. (2013) BMP signaling in mesenchymal stem cell differentiation and bone formation. J. Biomed. Sci. Eng. 6, 32-52.
81. Shi, S., de Gorter, D. J., Hoogaars, W. M., 't Hoen, P. A., ten Dijke, P. (2013) Overactive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophy. Cell Mol Life Sci. 70, 407-423.
82. Krause, C., Guzman, A., and Knaus, P. (2011) Noggin. Int. J. Biochem. Cell Biol. 43, 478-481.
83. Gamer, L. W., Cox, K., Carlo, J. M., and Rosen, V. (2009) Overexpression of BMP3 in the developing skeleton alters endochondral bone formation resulting in spontaneous rib fractures. Dev Dyn. 238, 2374-2381.
84. Tsartsalis, A. N., Dokos, C., Kaiafa, G. D., Tsartsalis, D. N., Kattamis, A., et al. (2012) Statins, bone formation and osteoporosis: hope or hype? Hormones (Athens) 11, 126-139.
85. Bleedorn, J. A., Sullivan, R., Lu, Y., Nemke, B., Kalscheur, V., et al. (2014) Percutaneous lovastatin accelerates bone healing but is associated with periosseous soft tissue inflammation in a canine tibial osteotomy model. J. Orthop. Res. 32, 210-216.
86. Zhang, Y., Bradley, A. D., Wang, D., and Reinhardt, R. A. Statins, bone metabolism and treatment of bone catabolic diseases. Pharmacol. Res., in press.
87. Chen, P. Y., Sun, J. S., Tsuang, Y. H., Chen, M. H., Weng, P. W., et al. (2010) Lin FH. Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway. Nutr. Res. 30, 191-199.
88. Moon, J. S., Oh, S. H., Jeong, Y. W., Kang, J. H., Park, J. C., et al. (2014) Relaxin augments BMP 2-induced osteoblast differentiation and bone formation. JBMR, 29, 1586-1596.
89. Ferlin, A., Pepe, A., Facciolli, A., Gianesello, L., and Foresta, C. (2010) Relaxin stimulates osteoclast differentiation and activation. Bone 46, 504-513.
90. Zhang, Q., He, Q. F., Zhang, T. H., Yu, X. L., Liu, Q., et al. (2012) Improvement in the delivery system of bone morphogenetic protein-2: a new approach to promote bone formation. Biomed. Mater. 7, 045002.
91. Poldervaart, M. T., Wang, H., van der Stok, J., Weinans, H., Leeuwenburgh, S. C., et al. (2013) Sustained release of BMP-2 in bioprinted alginate for osteogenicity in mice and rats. PLoS One 8, e72610.
92. Rahman, C. V., Ben-David, D., Dhillon, A., Kuhn, G., Gould, T. W., et al. (2014) Controlled release of BMP-2 from a sintered polymer scaffold enhances bone repair in a mouse calvarial defect model. J. Tissue Eng. Regen. Med. 8, 59-66.
93. Schwabe, P., Greiner, S., Ganzert, R., Eberhart, J., Dahn, K., et al. (2012) Effect of a novel non-viral gene delivery of BMP-2 on bone healing. Scientific WorldJournal. 2012, 560142.
94. Jun, S. H., Lee, E. J., Jang, T. S., Kim, H. E., Jang, J. H., et al. (2013) Bone morphogenic protein-2 (BMP-2) loaded hybrid coating on porous hydroxyapatite scaffolds for bone tissue engineering. J. Mater. Sci. Mater. Med. 24, 773-782.
95. Moshiri, A., Oryan, A., Meimandi-Parizi, A., Silver, I. A., Tanideh, N., et al. (2013) Effectiveness of hybridized nano- and microstructure biodegradable, biocompatible, collagen-based, three-dimensional bioimplants in repair of a large tendon-defect model in rabbits. J. Tissue Eng. Regen. Med., in press.
96. Oryan, A., Moshiri, A., Parizi Meimandi, A., and Silver, I. A. (2013) A long-term in vivo investigation on the effects of xenogenous based, electrospun, collagen implants on the healing of experimentally-induced large tendon defects. J. Musculoskelet. Neuronal Interact. 13, 353-367.
97. Lyon, T., Scheele, W., Bhandari, M., Koval, K. J., Sanchez, E. G., et al. (2013) Efficacy and safety of recombinant human bone morphogenetic protein-2/calcium phosphate matrix for closed tibial diaphyseal fracture: a double-blind, randomized, controlled phase-II/III trial. J. Bone Joint Surg. Am. 95, 2088-2096.
98. Haidar, Z. S., Hamdy, R. C., and Tabrizian, M. (2009) Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: current challenges in BMP delivery. Biotechnol. Lett. 31, 1817-1824.
99. Sharma, A., Meyer, F., Hyvonen, M., Best, S. M., Cameron, R. E., et al. (2012) Osteoinduction by combining bone morphogenetic protein (BMP)-2 with a bioactive novel nanocomposite. Bone Joint Res. 1, 145-151.
100. Meimandi-Parizi, A., Oryan, A., and Moshiri, A. (2013) Role of tissue engineered collagen based tridimensional implant on the healing response of the experimentally induced large Achilles tendon defect model in rabbits: a long term study with high clinical relevance. J. Biomed. Sci. 20, 28.
101. Meimandi-Parizi, A., Oryan, A., Moshiri, A., and Silver, I. A. (2013) Novel application of a tissue-engineered collagen-based three-dimensional bio-implant in a large tendon defect model: a broad-based study with high value in translational medicine. Tissue Cell 45, 282-294.
102. Moshiri, A., Oryan, A., and Meimandi Parizi, A. (2013) A novel application of biosynthetic tissue-engineered tridimensional implant on large tendon defects: a comprehensive, detailed, in vivo investigation with significant clinical value. Connect. Tissue Res. 54, 227-243.
103. Guzman, R., Nardecchia, S., Gutierrez, M. C., Ferrer, M. L., Ramos, V., et al. (2014) Chitosan scaffolds containing calcium phosphate salts and rhBMP-2: In vitro and in vivo testing for bone tissue regeneration. PLoS One 9, e87149.
104. Yilgor, P., Sousa, R. A., Reis, R. L., Hasirci, N., and Hasirci, V. (2010) Effect of scaffold architecture and BMP-2/BMP-7 delivery on in vitro bone regeneration. J. Mater. Sci. Mater. Med. 21, 2999-3008.
105. Yun, Y. P., Kim, S. E., Kang, E. Y., Kim, H. J., Park, K., et al. (2013) The effect of bone morphogenic protein-2 (BMP-2)-immobilizing heparinized-chitosan scaffolds for enhanced osteoblast activity. Tissue Eng. Regen. Med. 10, 122-130.
106. Zhang, S., Kucharski, C., Doschak, M. R., Sebald, W., and Uludag, H. (2010) Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery. Biomaterials 31, 952-963.
107. Wang, H., Zhang, F., Lv, F., Jiang, J., Liu, D., et al. (2014) Osteoinductive activity of ErhBMP-2 after anterior cervical diskectomy and fusion with a ß-TCP interbody cage in a goat model. Orthopedics 37, e123-e131.
108. Ono, M., Sonoyama, W., Nema, K., Hara, E. S., Oida, Y., et al. (2013) Regeneration of calvarial defects with Escherichia coli-derived rhBMP-2 adsorbed in PLGA membrane. Cell Tissue Organ 198, 367-76.
109. Schutzenberger, S., Schultz, A., Hausner, T., Hopf, R., Zanoni, G., et al. (2012) The optimal carrier for BMP-2: a comparison of collagen versus fibrin matrix. Arch. Orthop. Trauma Surg. 132, 1363-1370.
110. Lopiz-Morales, Y., Abarrategi, A., Ramos, V., Moreno-Vicente, C., Lopez-Duran, L., et al. (2010) In vivo comparison of the effects of rhBMP-2 and rhBMP-4 in osteochondral tissue regeneration. Eur. Cell Mater. 20, 367-378.
111. Fan, J., Park, H., Lee, M. K., Bezouglaia, O., Fartash, A., et al. (2014) Adipose derived stem cells and BMP-2 delivery in chitosan-based 3D constructs to enhance bone regeneration in a rat mandibular defect model. Tissue Eng. Part A. 20, 2169-2179.
112. Wilson, C. G., Martín-Saavedra, F. M., Vilaboa, N., and Franceschi, R. T. (2013) Advanced BMP gene therapies for temporal and spatial control of bone regeneration. J. Dent. Res. 92, 409-417.
113. Betz, O. B., Betz, V. M., Abdulazim, A., Penzkofer, R., Schmitt, B., et al. (2010) The repair of critical-sized bone defects using expedited, autologous BMP-2 gene-activated fat implants. Tissue Eng. Part A 16, 1093-1101.
114. Elangovan, S., D'Mello, S. R., Hong, L., Ross, R. D., Allamargot, C., et al. (2014) The enhancement of bone regeneration by gene activated matrix encoding for platelet derived growth factor. Biomaterials 35, 737-747.
115. Yang, H. S., La, W. G., Bhang, S. H., Lee, T. J., Lee, M., et al. (2011) Apatite-coated collagen scaffold for bone morphogenetic protein-2 delivery. Tissue Eng. Part A 17, 2153-2164.
116. Arzi, B., Verstraete, F. J., Huey, D. J., Cissell, D. D., and Athanasiou, K. A. (2014) Regenerating mandibular bone using rhBMP-2: part 1-immediate reconstruction of segmental mandibulectomies. Vet. Surg., in press.
117. Brown, K. V., Li, B., Guda, T., Perrien, D. S., Guelcher, S. A., et al. (2011) Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release. Tissue Eng. Part A 17, 1735-1746.
118. Jung, S. Y., KO, Y. J., Jang, H. S., Kang, S. W., and Park, J. H. (2013) The effect of carrier for BMP-2 delivery on histological aspects of tissue-engineered bone. J. Tissue Eng. Regen. Med. 10, 341-346.
119. Cao, L., Wang, J., Hou, J., Xing W., and Liu, C. (2014) Vascularization and bone regeneration in a critical sized defect using 2-N, 6-O-sulfated chitosan nanoparticles incorporating BMP-2. Biomaterials 35, 684-698.
120. Fu, Y., Zhang, Q., Sun, Y., Liao, W., Bai, X., et al. Controlled-release of bone morphogenetic protein-2 from a microsphere coating applied to acid-etched Ti6AL4V implants increases biological bone growth in vivo. J. Orthop. Res. 32, 744-51.
121. Gerard, D. A., Carlson, E. R., Gotcher, J. E., and Pickett, D. O. (2014) Early inhibitory effects of zoledronic acid in tooth extraction sockets in dogs are negated by recombinant human bone morphogenetic protein. J. Oral Maxillofac. Surg. 72, 61-66.
122. Koo, K. H., Ahn, J. M., Lee, J. M., Kim, B. S., Kim, C. S., et al. (2014) Apatite-coated collagen sponge for the delivery of bone morphogenetic protein-2 in rabbit posterolateral lumbar fusion. Artif. Organs, in press.
123. Chen, L., Lu, X., Li, S., Sun, Q., Li, W., et al. (2012) Sustained delivery of BMP-2 and platelet-rich plasma-released growth factors contributes to osteogenesis of human adipose-derived stem cells. Orthopedics 35, e1402-e1409.
124. Su, C. C., Kao, C. T., Hung, C. J., Chen, Y. J., Huang, T. H., et al. (2014) Regulation of physicochemical properties, osteogenesis activity, and fibroblast growth factor-2 release ability of β-tricalcium phosphate for bone cement by calcium silicate. Mater. Sci. Eng. C Mater. Biol. Appl. 37, 156-163.
125. Sohier, J., Daculsi, G., Sourice, S., de Groot, K., and Layrolle, P. (2010) Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering. J. Biomed. Mater. Res. A 92, 1105-1114.
126. Chen, Z., Wu, C., Gu, W., Klein, T., Crawford, R., et al. (2014) Osteogenic differentiation of bone marrow MSCs by β-tricalcium phosphate stimulating macrophages via BMP2 signalling pathway. Biomaterials 35, 1507-1518.
127. Rajangam, T., and An, S. S. (2013) Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications. Int. J. Nanomed. 8, 3641-3662.
128. Mogosanu, G. D., Grumezescu, A. M., Chifiriuc, M. C. (2014) Keratin-based biomaterials for biomedical applications. Curr. Drug Targets 15, 518-530.
129. de Guzman, R. C., Saul, J. M., Ellenburg, M. D., Merrill, M. R., Coan, H. B., et al. (2013) Bone regeneration with BMP-2 delivered from keratose scaffolds. Biomaterials 34, 1644-1656.
130. Carragee, E.J., Chu, G., Rohatgi, R., Hurwitz, E.L., Weiner, B.K., et al. (2013) Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. J. Bone Joint Surg. Am. 95, 1537-1545.
131. Crandall, D. G., Revella, J., Patterson, J., Huish, E., Chang, M., et al. (2013) Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease-part 1: large series diagnosis related outcomes and complications with 2- to 9-year follow-up. Spine (Phila Pa 1976) 38, 1128-1136.
132. Marx, R. E., Armentano, L., Olavarria, A., and Samaniego, J. (2013) rhBMP-2/ACS grafts versus autogenous cancellous marrow grafts in large vertical defects of the maxilla: an unsponsored randomized open-label clinical trial. Int. J. Oral Maxillofac. Implants 28, e243-251.
133. Fourman, M. S., Borst, E. W., Bogner, E., Rozbruch, S. R., and Fragomen, A. T. (2014) Recombinant human BMP-2 increases the incidence and rate of healing in complex ankle arthrodesis. Clin. Orthop. Relat. Res. 472, 732-739.
134. Roh, J. S., Yeung, C. A., Field, J. S., and McClellan, R. T. (2013) Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis. J. Orthop. Surg. Res. 8, 49.
135. Nandyala, S. V., Marquez-Lara, A., Fineberg, S. J., Pelton, M., and Singh, K. (2014) Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion. Spine (Phila Pa 1976) 39, 185-191.
136. Hurlbert, R. J., Alexander, D., Bailey, S., Mahood, J., Abraham, E., et al. (2013) rhBMP-2 for posterolateral instrumented lumbar fusion: a multicenter prospective randomized controlled trial. Spine (Phila Pa 1976) 38, 2139-2148.
137. Chen, Z., Ba, G., Shen, T., and Fu, Q. (2012) Recombinant human bone morphogenetic protein-2 versus autogenous iliac crest bone graft for lumbar fusion: a meta-analysis of ten randomized controlled trials. Arch. Orthop. Trauma Surg. 132, 1725-1740.
138. Coomes, A. M., Mealey, B. L., Huynh-Ba, G., Barboza-Arguello, C., Moore, W. S., et al. (2014) Buccal bone formation after flapless extraction: a randomized controlled clinical trail comparing recombinant human bone morphogenetic protein-2/absorbable collagen barrier and collagen sponge alone. J. Periodontol. 85, 525-535.
139. Singh, K., Nandyala, S. V., Marquez-Lara, A., Cha, T. D., Khan, S. N., et al. (2013) Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion. Spine J. 13, 1118-1125.
140. Gressot, L. V., Patel, A. J., Hwang, S. W., Fulkerson, D. H., and Jea, A. (2014) Rh-BMP-2 for L5-S1 arthrodesis in long fusions to the pelvis for neuromuscular spinal deformity in the pediatric age group: analysis of 11 patients. Childs Nerv. Syst. 30, 249-255.
141. Kim, Y. J., Lee, J. Y., Kim, J. E., Park, J. C., Shin, S. W. et al. (2014) Ridge preservation using demineralized bone matrix gel with rhBMP-2 following tooth extraction: a randomized controlled clinical trial. J. Oral Maxillofacial Surg. 72, 1281-1290.
142. Zimmermann, G., Wagner, C., Schmeckenbecher, K., Wentzensen, A., and Moghaddam, A. (2009) Treatment of tibial shaft non-unions: bone morphogenetic proteins versus autologous bone graft. Injury 40, S50-S53.
143. Fu, R., Selph, S., McDonagh, M., Peterson, K., Tiwari, A., et al. (2013) Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis. Ann. Intern. Med. 158, 890-902.
144. Moatz, B. and Tortolani, P. J. (2013) Transforaminal lumbar interbody fusion and posterior lumbar interbody fusion utilizing BMP-2 in treatment of degenerative spondylolisthesis: neither safe nor cost effective. Surg. Neurol. Int. 4, S67-S73.
145. Woo, E. J. (2013) Adverse events after recombinant human BMP2 in nonspinal orthopaedic procedures. Clin. Orthop. Relat. Res. 471, 1707-1711.
146. Bae, H.W., Zhao, L., Kanim, L.E., Wong, P., Marshall, D., et al. (2013) Bone marrow enhances the performance of rhBMP-2 in spinal fusion: a rodent model. J. Bone Joint Surg. Am. 95, 338-347.
147. Wong, E., Sangadala, S., Boden, S. D., Yoshioka, K., Hutton, W. C., et al. (2013) A novel low-molecular-weight compound enhances ectopic bone formation and fracture repair. J. Bone Joint Surg. Am. 95, 454-461.
148. Zhang, X., Liu, T., Huang, Y., Wismeijer, D., and Liu, Y. (2014) Icariin: does it have an osteoinductive potential for bone tissue engineering? Phytother. Res. 28, 498-509.
149. Parizi, A. M., Oryan, A., Shafiei-Sarvestani, Z., and Bigham, A. S. (2012) Human platelet rich plasma plus Persian Gulf coral effects on experimental bone healing in rabbit model: radiological, histological, macroscopical and biomechanical evaluation. J. Mater. Sci. Mater. Med. 23, 473-483.
150. Shafiei-Sarvestani, Z., Oryan, A., Bigham, A. S., and Meimandi-Parizi, A. (2012) The effect of hydroxyapatite-hPRP, and coral-hPRP on bone healing in rabbits: radiological, biomechanical, macroscopic and histopathologic evaluation. Int. J. Surg. 10, 96-101.
151. Xu, H., Ke, K., Zhang, Z., Luo, X., Jin, X., et al. (2013) Effects of platelet-rich plasma and recombinant human bone morphogenetic protein-2 on suture distraction osteogenesis. J. Craniofac. Surg. 24, 645-650.
152. Kim, T. H., Kim, S. H., Sandor, G. K., and Kim, Y. D. (2014) Comparison of platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit-skull defect healing. Arch. Oral Biol. 59, 550-558.
153. Moshiri, A., and Oryan, A. (2013) Role of platelet rich plasma in soft and hard connective tissue healing: an evidence based review from basic to clinical application. Hard Tissue 2, 6.
154. Marques, L. F., Stessuk, T., Camargo, I. C., Sabeh Junior, N., Santos, L. D., et al. (2014) Platelet-rich plasma (PRP): methodological aspects and clinical applications. Platelets, in press.
155. Bigham-Sadegh, A., Karimi I., Alebouye M., Shafie-Sarvestani, Z., Oryan, A. (2013) Evaluation of bone healing in canine tibial defects filled with cortical autograft, commercial-DBM, calf fetal DBM, omentum and omentum-calf fetal DBM. J. Vet. Sci. 14, 337-343.
156. Tilkeridis, K., Touzopoulos, P., Ververidis, A., Christodoulou, S., Kazakos, K., et al. (2014) Use of demineralized bone matrix in spinal fusion. World J. Orthop. 5, 30-37.
157. Jiang, L., Sun, H., Yuan, A., Zhang, K., Li, D., et al. (2013) Enhancement of osteoinduction by continual simvastatin release from poly(lactic-co-glycolic acid)-hydroxyapatite-simvastatin nano-fibrous scaffold. J. Biomed. Nanotechnol. 9, 1921-1928.
158. Wang, F., Zhang, Y. C., Zhou, H., Guo, Y. C., and Su, X. X. (2014) Evaluation of in vitro and in vivo osteogenic differentiation of nano-hydroxyapatite/chitosan/poly(lactide-co-glycolide) scaffolds with human umbilical cord mesenchymal stem cells. J. Biomed. Mater. Res. A. 102, 760-768.
159. Mohan, B. G., Suresh Babu, S., Varma, H. K., and John, A. (2013) In vitro evaluation of bioactive strontium-based ceramic with rabbit adipose-derived stem cells for bone tissue regeneration. J. Mater. Sci. Mater. Med. 24, 2831-2844.
160. Calori, G. M., Colomboa, M., Mazza, E., Ripamonti, C., Mazzola S., et al. (2013) Monotherapy vs. polytherapy in the treatment of forearm non-unions and bone defects. Injury S1, S63-S69.
161. Inzana, J. A., Olvera, D., Fuller, S. M., Kelly, J. P., Graeve, O. A., et al. (2014) 3D printing of composite calcium phosphate and collagen scaffolds for bone regeneration. Biomaterials 35, 4026-4034.
162. Shim, J. H., Kim, S. E., Park, J. Y., Kundu, J., Kim, S. W., et al. (2014) Three-dimensional printing of rhBMP-2-loaded scaffolds with long-term delivery for enhanced bone regeneration in a rabbit diaphyseal defect. Tissue Eng Part A 20, 1980-1992.
163. Moshiri, A. and Oryan, A. (2012) Role of tissue engineering in tendon reconstructive surgery and regenerative medicine: current concepts, approaches and concerns. Hard Tissue 1, 11.
164. Dawson, J. I., Kanczler, J., Tare, R., Kassem, M., and Oreffo, R. O. (2014) Concise review: bridging the gap: bone regeneration using skeletal stem cell-based strategies - where are we now? Stem Cells 32, 35-44.
165. Song, T., Wang, W., Xu, J., Zhao, D., Dong, Q., et al. (2013) Fibroblast growth factor 2 inhibits bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells by repressing Smads signaling and subsequently reducing Smads dependent up-regulation of ALK1 and ALK2. Int. J. Biochem. Cell Biol. 45, 1639-1646.